Evidence map›Paper›PMID 38476737›Full record

ReviewTherapeutic advances in infectious disease

Short-term

Santiago Grillo Perez, Candida Diaz-Brochero, Javier Ricardo Garzon Herazo, Oscar Mauricio Muñoz Velandia

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Santiago Grillo PerezDepartment of Internal Medicine, Hospital Universitario San Ignacio, Carrera 7 No 40-62, 7th Floor, Bogotá 110231, Colombia.ORCID https://orcid.org/0000-0002-3457-565X
Candida Diaz-BrocheroPontifical Xavierian University, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-2176-7388
Javier Ricardo Garzon HerazoPontifical Xavierian University, Bogotá, Colombia.
Oscar Mauricio Muñoz VelandiaPontifical Xavierian University, Bogotá, Colombia.
Pontificia Universidad Javeriana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Uncomplicated Objective: To evaluate the efficacy and safety of short Methods: We developed a search strategy to identify systematic review and meta-analysis of non-randomized studies (NRS), comparing short Results: Six NRS with a total of 1700 patients were included. No significant differences were found when comparing short Conclusion: Shorter-duration regimens could be considered as an alternative option for uncomplicated SAB in low-risk cases. However, based on a small number of studies with significant methodological limitations and risk of bias, the benefits and harms of shorter regimens should be analyzed with caution. Randomized clinical trials are needed to determine the best approach regarding the optimal duration of therapy.

Indexed as

antibiotic durationbacteremiameta-analysisStaphylococcus aureussystematic review

Identifiers

PMID38476737
PMCPMC10929032
OpenAlexW4392665993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.